D-Wave Quantum Inc. Form 8-K Summary
Business Context and Reporting Period
D-Wave Quantum Inc. filed a Current Report on Form 8-K dated August 16, 2022, reporting the issuance of a press release covering financial results for the second quarter ended June 30, 2022.
The filing identifies D-Wave as a Delaware corporation headquartered in Burnaby, British Columbia. Its common stock trades on the New York Stock Exchange under QBTS, and its warrants trade under QBTS.WS.
Financial Results and Key Metrics
The filing incorporates by reference a press release designated as Exhibit 99.1, but the supplied filing text does not include the press release's financial data. Revenue, profit or loss, cash flow, margins, debt, liquidity, and other operating metrics are therefore not clearly provided.
Material Changes Versus Prior Period
The filing text does not provide a clear comparison with the prior comparable period or identify specific changes in financial performance.
Guidance, Outlook, Risks, and Unusual Items
- No guidance or quantitative outlook is included in the supplied filing text.
- No management commentary, material risks, contingencies, or unusual items are described beyond the announcement of second-quarter results.
- The information in the Form 8-K and accompanying exhibit is furnished rather than filed for purposes of Section 18 of the Exchange Act and is not incorporated by reference into other filings unless expressly incorporated.
- D-Wave is identified as an emerging growth company.
Investor Verification Points
- Obtain and review Exhibit 99.1 for the actual second-quarter revenue, earnings, cash flow, liquidity, and operating metrics.
- Verify any year-over-year or sequential-period comparisons and management guidance contained in the press release.
- Review the company's broader periodic filings for debt, capital resources, contractual obligations, and risk disclosures.
- Confirm the terms and potential dilution associated with the listed warrants, including the stated exercise ratio of 1.4541326 shares per whole warrant and $11.50 exercise price.